In Vivo Brain Concentrations of N-Acetyl Compounds, Creatine, and Choline in Alzheimer Disease
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Alzheimer disease (AD) and normal aging result in cortical gray matter volume deficits. The extent to which the remaining cortex is functionally compromised can be estimated in vivo with magnetic resonance spectroscopic imaging. OBJECTIVE: To assess the effects of age and dementia on gray matter and white matter concentrations of 3 metabolites visible in the proton spectrum: N-acetyl compounds, present only in living neurons; creatine plus phosphocreatine, reflecting high-energy phosphate metabolism; and choline, increasing with membrane synthesis and degradation. METHOD: Fifteen healthy young individuals, 19 healthy elderly individuals, and 16 patients with AD underwent 3-dimensional magnetic resonance spectroscopic imaging and memory and language testing. RESULTS: Gray matter N-acetyl compound concentrations (signal intensity corrected for the amount of brain tissue contributing to the magnetic resonance spectroscopic imaging signal) was significantly reduced only in patients with AD, even though both the AD and elderly control groups had substantial gray matter volume deficits relative to the young control group. Both the healthy elderly and AD groups had abnormally high gray matter creatine plus phosphocreatine concentrations. Gray matter choline concentrations were higher in the elderly than the younger controls, and even higher in the AD group than in the elderly control group. Functional significance of these findings was supported by correlations between poorer performance on recognition memory tests and lower gray matter N-acetyl compounds in elderly controls and higher gray matter creatine plus phosphocreatine and choline concentrations in patients with AD. CONCLUSION: Cortical gray matter volume deficits in patients with AD are accompanied by disease-related increases in gray matter choline concentrations suggestive of cellular degeneration and reduced N-acetyl compound concentrations, with possible effects on behavioral function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499 · cited 1×
“Patients met National Institute of Neurological and Communicative Diseases and Stroke– Alzheimer’s Disease and Related Disorders Association criteria for probable Alzheimer disease.(61,62) Controls were recruited from the local community.”
MethodPfefferbaum, A., Mathalon, D. H., Sullivan, E. V., Rawles, J. M., Zipursky, R. B., & Lim, K. O. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210046012 · Cited by 1,363
Self-citationWhite matter changes with normal aging.
Guttmann, C. R. G., Jolesz, F. A., Kikinis, R., Killiany, R. J., Moss, M. B., Sandor, T., & Albert, M. S. (1998) · Neurology · doi:10.1212/wnl.50.4.972 · Cited by 466
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
Seab, J. P., Jagust, W. J., Wong, S. T. S., Roos, M. S., Reed, B. R., & Budinger, T. F. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910080210 · Cited by 364 · cited 1×
“A LZHEIMER DISEASE (AD) results in substantial loss of brain tissue.(1-15) This decline is attributable to deterioration of cell processes, shrinkage of neurons, and perhaps neuronal death.”
MethodAlzheimer's disease affects limbic nuclei of the thalamus
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00305867 · Cited by 328
EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS
De Leon, M., George, A., Stylopoulos, L., Smith, G., & Miller, D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90911-2 · Cited by 284 · cited 1×
“A LZHEIMER DISEASE (AD) results in substantial loss of brain tissue.(1-15) This decline is attributable to deterioration of cell processes, shrinkage of neurons, and perhaps neuronal death.”
MethodBraak, H., & Braak, E. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90032-9 · Cited by 181 · cited 1×
“This decline is attributable to deterioration of cell processes, shrinkage of neurons, and perhaps neuronal death.(10,16-20) Healthy elderly individuals show an age-related gray matter volume decline in the neocortex(21-24) (see Guttman et al(25)) but their volume loss may not be accompanied by neuronal death.”
Background
Cited by
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
NORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.317 · Cited by 371
Frontal circuitry degradation marks healthy adult aging: Evidence from diffusion tensor imaging
Pfefferbaum, A., Adalsteinsson, E., & Sullivan, E. V. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.034 · Cited by 355
Self-citationMembrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids
Klein, J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070051 · Cited by 303
1 H MR spectroscopy in common dementias
Kantarci, K., Petersen, R. C., Boeve, B. F., Knopman, D. S., Tang-Wai, D. F., O’Brien, P. C., Weigand, S. D., Edland, S. D., Smith, G. E., Ivnik, R. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000141849.21256.ac · Cited by 262
Metadata
- Authors
- Pfefferbaum, A., Adalsteinsson, E., Spielman, D., Sullivan, E. V., & Lim, K. O.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1999-02-01
- Volume
- 56
- Issue
- 2
- Pages
- 185
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2117312470
- Cited by
- 134
- References
- 8
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vivo Brain Concentrations of N-Acetyl Compounds, Creatine, and Choline in Alzheimer Disease. https://app.cochat.ai/papers/10.1001/archpsyc.56.2.185
- The paper
- Pfefferbaum, A., Adalsteinsson, E., Spielman, D., Sullivan, E. V., & Lim, K. O. (1999). In Vivo Brain Concentrations of N-Acetyl Compounds, Creatine, and Choline in Alzheimer Disease. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.56.2.185
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.